Clinical Trial Update: A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for NS2 in allergic conjunctivitis shows completed status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Seasonal Allergies

Drugs mentioned

• NS2

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Allergic Conjunctivitis, Seasonal Allergies | Phase 2 | Status: COMPLETED | Results posted: 2023-12-05